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The capacity to mount an lgE antibody response to 
antigen differentiates normal from allergic individuals. 
The frequent association of high serum IgE with T cell 
immunodeficiencies suggest a role for T cells in the 
regulation of human IgE. Peripheral blood lymphocytes 
(PBL) from allergic individuals spontaneously secrete 
IgE in vitro whereas normal PBL do not. Unlike the 
situation with other isotypes the polyclonal B-cell acti-
vators, pokeweed mitogen, and Epstein-Barr virus, do 
not induce IgE synthesis in normal B cells. However, 
normal B cells synthesize IgE when cultured with T cell 
clones that recognize determinants expressed by the B 
cells. B cells from allergic subjects but not from normal 
subjects are induced to secrete IgE via a bystander effect 
when cultured with T cell clones which are stimulated 
by antigenic determinants not expressed by the B cells. 
T cells with Fe receptors for IgE can be isolated from 
patients with hyper IgE syndrome and maintained as 
long term continuous T cell lines or T-T hybridomas. 
These cells secrete IgE binding factors which enhance 
IgE synthesis by preactivated IgE bearing B cells from 
aiiergic subjects but not resting B ceiis from normal 
donors. The phenotype of these Fe R+ IgE-potentiating 
T ceil lines are predominantly T3+ T4+ Ia+. IgE binding 
factors have been isolated from normal serum and selec-
tively suppress IgE synthesis. In contrast IgE binding 
factors isolated from patients with hyper IgE syndrome 
contain IgE-potentiating activity as well as lgE sup-
pressor activity. 
These results suggest that in allergic individuals lgE 
B cells are activated by T cells and their antibody secre-
tion is modulated by lgE binding factors. 
The IgE ant ibody system plays an important role in the 
pathogenesis of human a ll ergic diseases [1 ,2]. These diseases 
include atopic dermati t is (AD), allergic rhinitis, and asthma. 
The importan t link between IgE and allergic disease is further 
substan t iated by the observation that children with elevated 
serum lgE during t he first yea r of life have a significant ly 
increased probability of developing clinical manifestations of 
allergy later in childhood. 
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PBMC: peripheral blood mononuclea r cells 
PWM: pokeweed mitogen 
Despite considerab le advances in many areas of modern 
medici ne, the fundamental t herapeut ic a lternatives available 
to patients with allergic diseases have not changed in t he past 
decade. A detailed understanding of t he mechanisms regulating 
t he human IgE response will be importa nt in t he development 
of new, effective therapeut ic approaches to t his group of dis-
eases. Moreover, t here is growing evidence suggesting that t he 
lgE an t ibody plays an important gatekeeper role in the body's 
defense mechanisms and in fac ili tating the loca l deposition of 
circulating immune complexes. Aside from its well established 
role in the elimination of parasitic infect ions, IgE may play an 
important defense role agai nst exogenous an t igens which pen-
etrate t he mucosal and ep ithelial linings of t he respiratory 
t ract, gastroin testinal tract, and skin. Following t he interaction 
of such ant igens with IgE bound to mast cells, mediators are 
released which t rigger a marked inflammatory response, loca l-
ization of t he ant igen, and alteration of vascular permeability 
to allow t he infiltration of other components of t he immune 
system. Treatment of experimental animals with antihistamine 
prior to t he induction of circulating immune-complexes has 
been reported to prevent t he deposit ion of immune complexes 
into t issues. Such experiments suggest t hat t he IgE-mast cell 
system may play a role in triggering the inflammatory response 
of immune complex-mediated vasculitides. Thus, an under-
standing of the regulation of lgE synthesis has implications not 
only fo r t he treatment of allergic diseases but fo r an under-
standing of t he body's sophisticated defense system and in 
pathologic conditions, the deposit ion of immune complexes. 
This review will focus on current concepts of the mechanisms 
controlling the human IgE response. Until recently, the inves-
tigation of such mechanisms has been hindered by t he limited 
availability of experimental systems which reproducibly acti-
vate in vi t ro IgE synthesis. Most reports have t herefore focused 
on the function of peripheral blood T and B cells from patients 
with diseases characterized by exceptionally high levels of 
serum IgE. It was hoped that by understanding t he basis for 
elevated IgE levels in t hese various pathologic states the role 
played by t he different components of t he immune system in 
generating t he human IgE response could be elucidated. Despite 
the limitations of such studies, it appea rs that t here are striking 
similarit ies in t he mechanisms by which T cells control lgE 
synthesis in humans and rodents. 
At present, there is substantial evidence to support the 
concept t hat the requirements for activation of IgE synthesis 
differ from those required for synthesis of other immunoglob-
ulin isotypes. Using rodent model systems, Ishizaka [3] has 
demonstrated that IgE binding factors secreted by T cells which 
bear Fe receptors for lgE (Fc,R) play an important role in t he 
isotype-specitic regulat ion of IgE synthesis. During t he course 
of this review we will summarize experiments which suggest 
that t he human IgE ant ibody response is also regulated by T 
cell-derived soluble factors which bind to IgE. 
THE ROLE OF T CELLS IN THE REG ULATION OF 
IGE SYNTHESIS 
Studies in Rodent Models 
The important role played by T cells in t he generation of t he 
IgE antibody response was first demonstrated by a series of 
experiments carried out in t he early 1970s. Thus, Okumura and 
Tada [4] first demonstrated that neonatally t hymectomized 
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TABLE I. Properties of rat T cell-derived lgE binding factors 
Molecu la r weight 
Affi ni ty fo r lgE 
Affini ty fo r len t il lectin 
Af'fini ty for concanavalin A 
Affini ty fo r peanu t agglu -
t in in 
Sens it ivi ty to t ryps in 
Se nsit ivity to neuraminidase 
IgE potent i ati n ~: I ~E suppressive 
~~m ~ctm 
13,000- 15,000 13,000- 15,000 
+ + 
+ 
+ 
+ 
+ + 
+ 
rats were unable to generate lgE a nt ibody responses. Subse-
que nt studies carri ed out in rodents de monstrated that lgE 
synthes is was regulated by a balance between two distinct T 
cell subpopulations (i.e., helpe r/ inducer T ce ll s required for t he 
induction and enhancement of lgE synt hesis, and suppresso r 
T cells which inhibit lgE synt hes is). Low lgE responder rodents 
appea r to have increased num bers or fun ction of lgE isotype 
spec ific suppresso r T cell s because lge ant ibody responses in 
such animals can be enhanced through experimenta l manipu-
lations which selectively deplete lgE suppressor T cell s. Thus, 
Tad a and co-workers f 4·,5) used the rat model to demonstrate 
t hat sublethal doses of whole body irradiation, or administra-
tion of immunosuppressive d rugs such as cyclophosphamide, 
converted rats from t heir characte ristic pattern of t ransitory, 
low level lgE production to a pattern of sustained elevated lgE 
synthes is. T he observation t hat such increased IgE responses 
in rats could be te rminated by passive t ransfe r of syngeneic T 
ce ll s [6] provided direct ev idence that the limited lgE response 
patte rns in unmanipulated rats refl ected the dominance of a 
suppresso r T cell regu latory cont rol mechanism that normally 
serve to minimize the production of ant ibody of t he IgE class. 
It should be noted that t he above expe rimenta l measures selec-
t ive ly a ffected IgE bu t not lgG responses support ing t he notion 
t hat the reg-ulation of these two isotypes is quali tatively and/ 
or quant itat ively different. 
Ishi zaka [3] has reported that lgE-spec ific regulatory T cell s 
bea r Fe recepto rs for fgE. T hese T ce ll s sec rete low molecular 
we ight glycop roteins which bind to lgE (i.e., lg~ binding fac-
tors). T hese JgE binding facto rs act on JgE-beanng memory B 
ce lls and regu late t heir diffe rent iat ion in to lgE-secreting 
plas ma cell s. lgE-specific regul ato ry T cell s are activated by 
seve ra l signa ls following ant igen activation. T he first signal 
causes T ce ll s bea ring Fe recepto rs fo r lgG to display a recepto r 
for the FC port ion of JgE and to synthes ize and sec rete lgE 
binding facto rs. These facto rs, howeve r, have no biologic activ-
ity. T heir biologic activity is dependent on the presence of 
addit ional signa ls which regu late glycosylation of the lgE bind-
ing facto rs. T hese glycosy lation s igna ls are deriv~d. from a 
discrete subset of T ce lls and ca n be induced by adm1n1strat10 n 
of the ap propriate adju va nts. Adjuva nts such as alum or para-
sitic antige ns resul t in the sec retion of glycosy lation-enhancing 
factors. T hi s factor acts on the T ce ll s t hat produce t he lgE 
binding facto rs to promote the glycosylation of these facto rs. 
Glycosy lated-lgE binding facto rs potent iate lgE synthes is. In 
cont rast, adjuva nts such as complete Freund's adjuvants cause 
a di sc rete subpopulation ofT ce ll s to sec rete a glycosylation-
inhibit ion factor which p romotes t he secretion of poorly gly-
cosylated lgE binding facto rs that suppress lgE but not lgE 
synt hesis. A compari son of the prope rties of these two JgE 
bind ing factors is shown in T able I. 
Association of Elevated S erum I~E with Hu man T Cell 
1 mm.unudeficiency Diseases 
Despi te the extensive data avail able in rodent. models con-
ce rning the mechani sms by which IgE synthes is is regu lated, 
similar expe riments have not been ca rried out in humans 
because ana logous in vivo experiments are not possible. The 
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most convincing in vivo evidence that T cells play an important 
role in t he regulation of human lgE synthesis is derived from 
the frequent obse rvation of elevated serum lgE levels in pa-
tients with T cell immunodefi ciencies [7). Thus, increased 
serum lgE levels have been reported in patients wi t h Di 
Geo rge's syndrome, ataxia-telangiectasia, and Wiskott-Aldrich 
syndrome. It has been postulated that t hese patients may have 
sufficient numbers of helper T cells to initiate IgE synt hesis 
but an inadequate number of suppresso r T cells to inhibit lgE 
synthesis, t hus, resulting in increased production of IgE. This 
hypothes is is supported by t he observation that several diseases 
characterized by dec reased number and function of suppressor 
T cells a re accompanied by extremely high serum lgE levels. 
Thus, patients wit h t he hyper JgE syndrome (HIE) (extremely 
elevated serum lgE, recurrent infections, chronic pruritic der-
matitis) have been reported to have a selective deficiency of 
T3+ T8+ suppressor/cytotox ic T cells but not of T 3+ T 4+ 
helper/ inducer T cell s in t heir circulation. Evaluation of pe-
ripheral blood mononuclear cells (PBMC) from patients with 
HIE have also revealed an inability to ge nerate fun ctional 
suppresso r T cell activity following a 48-h incubation with 
concanavalin A [8). Similarly, patients wi th severe atopic der-
matit is and elevated serum lgE levels have also been found to 
have decreased numbers of circulating T 8+ suppressor/cyto-
tox ic T cells [9,10] . Using enumeration of the Fe receptor for 
IgG (Fc~R) as a marker fo r suppressor T cells, Cooper eta! [11) 
reported a decreased number of circulati ng T cells in AD. 
Furthermore, t hese investigators found a direct correlation 
between decreased number of Fc~R+ T cells and elevations in 
serum IgE. 
Fina lly, close monitoring of serum lgE levels fo llowing allo-
ge neic bone marrow t ransplant reveals t hat recipients develop 
extremely high serum lgE levels at the onset of acute graft-
versus-host (GVH) disease [12). The lgE levels return to nor-
mal with resolution of GVH disease. The basis for increased 
lgE levels in patients with acute GVH is believed to be due in 
part to an imbalance of T cell help and T cell suppression 
because patients wi th acute GVH have increased numbers of 
circulating T cells expressing the HLA-DR activation ant igen 
and decreased numbers of suppressor T cel ls [13]. T hese ex-
perime nts of nature are compatible with observations made in 
rodent models which suggest that T cells play an important 
role in the regu lation of human IgE synthesis. 
S uppressor T Cells and Huma n. lgE Synthesis 
The potent ial importance of suppressor T cell s in t he regu-
lat ion of lgE synt hesis in man is based on the following obser-
vations: (1 ) selective deletion of suppressor T cells in low lgE 
responder rodents by either total body irradiation or immuno-
suppressive agents resul t in marked enhancement of lgE syn-
thesis; (2) se rum IgE levels are frequent ly elevated in the 
presence of normal IgG levels in many primary T cell immu-
nodeficiencies; and (3) certain diso rders such as the HIE, severe 
AD, and acute GVH disease are assoc iated with marked eleva-
t ion in se rum IgE and dec reased numbers of suppressor T cells. 
T o examine the role of suppressor T cells in atopic individ-
uals severa l laboratories have at tempted to develop in vit ro 
models of lgE synthesis. T o date , t he most common approach 
has been to study spon taneous lgE syn thesis by cultured PBMC 
from atopic and nonatopic donors. Numerous studies have 
reported t hat P BMC from patients with diseases characterized 
by elevated lgE levels synthesized abnormally large amounts 
of lgE spontaneously in vit ro whereas P BMC from nonatopic 
donors fa iled to synthesize IgE [14- 18]. This increased secre-
t ion of IgE was isotype restricted as concurrent IgG sec retion 
was not increased [8,14). Furthermore, IgE synthesis by P BMC 
from allergic rhini t is donors is higher following exposure to 
all ergens such as grass pollen or ragweed poll en [19,20]. It 
should be noted, however, t hat severa l investigato rs have re-
ported t hat as much as 40- 50% of lgE released into the super-
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natants of cu ltured PBMC from hyper IgE patients may rep-
resent lgE preformed in vivo. Therefore a ny experiments in -
volving t he measurement of de novo lgE synthesis by cultured 
atopic PBMC must include app ropriate background controls 
for measurement of preformed lgE. Treatment of PBMC with 
protein inhibi tors such as cyclohex imide, freeze-thawing 
PBMC on day 0 fo llowed by a 7-day cul ture period, and acid 
treatment of ce ll pellets at day 0 have all been suggested as 
appropriate methods to be used for assessment of background 
IgE secretion [21,22]. Neve rtheless, rega rdless of the cell con-
ditions used, a ll investigators have reported that B cells from 
atop ic donors make substant ially more IgE t han normal B ce lls 
in vitro. The basis for t his difference is not well understood but 
has important implications for understanding t he basis of the 
human reaginic response. 
Severa l laborato ries have examined the effects of normal T 
cell s on IgE production by cul tured PBMC from patients with 
severe AD a nd/o r t he HIE. In each case, unfractionated T cells 
from hap loident ica l or normal T cell s suppressed sponta neous 
de novo lgE production by cul tured PBMC from patie nts with 
t he HIE and/or seve re AD [8,15- 18]. S ince patients with HIE 
and severe AD have a selective defi ciency of circulating T8+ 
cells, Geha et a! [8] investigated t he effects of normal T8+ 
suppressor/cytotoxic T ce lls and T4+ helper/ inducer T cells 
on IgE synthesis by PBMC from these patients. lt was found 
that spontaneous de novo lgE synthesis by cu ltured PBMC 
from these patients could be suppressed by normal parental 
T8+ T cells but not T4+ T cells. However, since Katz [23] has 
demonstrated that allogeneic interactions result in the produc-
t ion of lgE-spec ific suppressor factors, t he possibility that 
results from the latter co-cu lture studies were due to allogeneic 
effects could not be excluded. In t hi s regard , we obse rved t hat 
abnormally elevated IgE synthes is by cu ltured PBMC from 
patients with acute GVH disease could be suppressed by T8+ 
ce ll s from normal histo iden t ical siblings [14]. Furthermore, T 
ce lls from patients who had recovered from acute GVH disease 
could effectively suppress lgE synthesis by thawed auto logous 
cu ltured PBMC that has been cryop rese rved during acute GVH. 
These resu lts supported the hypothesis that the elevated 
se rum lgE levels in severe AD, acute GVH disease and HIE 
were due in part to a relative deficiency of suppressor T cell s 
bearing the T8 su rface ant igen . 
REQUIREMENTS FOR THE INDUCTION OF IcE 
SYNTHESIS BY NORMAL B CELLS 
Role of Soluble Factors From Hyper lgE T Cells 
To date, most studies of human IgE synthesis in vitro have 
been restri cted to the detection of spontaneous lgE synthesis 
by in vivo activated lymphocytes from atopic donors. Such 
studies have been fraught with difficulties because t he amounts 
of lgE secreted into cul ture supernata nts are extremely small 
(in the picogram to few nonogram range). Since t hese same 
cu ltures frequent ly have 100- 1000 t imes more IgG present in 
t hem, it is crucia l t hat highly specific ant isera to lgE be used 
in the assays for JgE. Furthermore, as ment ioned above, pre-
formed lgE bound to ce ll membra nes of basophils, monocytes, 
T and B cell s has to be accurately determined and its value 
subtracted from the tota l lgE measured in cultures. Finally, it 
is likely t hat a significant proport ion of IgE produced in such 
cultu res are sec reted by te rminally differentiated IgE plasma 
cell s which are not subject to the same degree ofT cell regu la-
tion as resti ng B cell s. Thus, to further our understanding of 
the mechanisms controlling t he human lgE response t here has 
been conside rable interest in developing model systems in 
which in vitro lgE production can be induced in nonatopic 
subjects and augmented in atopic subjects. 
Since pokeweed mitogen (PWM) is a potent T ce ll dependent 
activato r of B ce ll s for JgG, JgA, and IgM synthesis, numerous 
laboratories have studied the ability of PWM to induce human 
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PBL to synthesize IgE. Confl icting results were obtained pri -
marily because some laboratories utilized antisera to IgE mye-
loma P.S. which cross-reacted with idiotypic determinants on 
polyclonal immunoglobulin of other isotypes [24]. In most 
studie including our own [14], when appropriately specific 
antisera was used, PWM failed to stimulate IgE synthesis by 
normal PBMC and inhibited IgE synthesis by atopic PBMC 
[14- 18] . Furthermore, T cell independent B cell activators such 
as Staphy lococcus aureus Cowan stra in and Epstein-Barr virus 
has also failed to induce normal B cells to produce IgE in vitro 
(14]. 
The failure of normal PBL to synt hesize IgE was not due to 
the presence of suppressor T cells of t he T8 phenotype. Indeed, 
elimination of T8+ suppressor T ce lls from PBMC by treat-
ment with OKT8 antibody and complement enhanced IgG 
production but did not reverse the inability of normal lympho-
cytes to synthesize IgE following stimulation with PWM or 
Epstein-Barr virus [14] . These resul ts suggested two possibili -
t ies: (1) IgE precursor B cells were not present in the ci rcu lation 
of normal donors; and (2) the activation of IgE B cells require 
T cell s igna ls not generated by normal T cells under experi -
mental conditions known to generate T cell for the differentia-
tion of IgG B cell s. The recent finding by Lanzavecchia (25] 
that alloreactive T cell clones can induce normal peripheral 
blood B cells to produce large amounts of IgE, IgG, and IgM 
suggests that IgE precursor B cells are present in the circula-
tion. 
Since PBMC from patients with the HIE, severe AD, and 
acute GVH disease spontaneously synt hesize high levels of lgE 
in vitro, we evaluated their T cells for the secretion of so luble 
factors capable of inducing IgE synthesis by normal B ce ll s 
[14,26 ). Purified peripheral blood T cells of patients suffering 
from these 3 hyper lgE states were cul tured at 1.0 x 107 cells/ 
ml in RPMI-1640 cu lture medium supplemented with 10% fetal 
calf serum. After 24 h, t he cu lture supernatants were collected 
and assessed for t heir ab ili ty to induce immunoglobulin syn-
thesis in cul tures of normal B cells. Supernatants of T cell s 
from patients with elevated serum lgE induced significant lgE 
synthesis by normal B cells whe1 eas supernatants from the T 
cell s of normal subjects did not induce IgE synt hesis by normal 
B ce lls. In cont rast, supernatants from T cells of hyper IgE 
patients and normal pat ients enhanced lgG synthesis by normal 
B cell s to the same degree. These resul ts suggest an isotype 
specific helper factor(s) for lgE was released by T cells from 
patients with elevated serum lgE. Recently, Romagnani et a! 
[27] have also reported that T cells fro m patients with severe 
AD secrete soluble factors which stimulate IgE but not lgG 
production in vitro by B ce lls from normal or grass pollen 
sensitive patients with allergic rhini t is. These results suggest 
that T cell s from hyper lgE patients but not normal donors 
secrete helper factors that are required for the induction of IgE 
synthesis by normal B cells. 
Characte ri zation of t his immune IgE-spec ific helper factor 
revealed t hat it sha red several physiochemical characteristics 
with t he lgE-potent iati ng factor described by Yodoi et a) 
[3,28]; (refer to tab le I). Treatment of t he hyper IgE T cell s 
with tunicamycin , a glycosylation inhibi tor, or cyclohex imide 
blocked the generation ofl gE helper facto r. Furthermore, treat-
ment ofT ce ll superna ta nts containing IgE helper factor with 
inso lubili zed trypsin or insolubili zed neuraminidase markedly 
reduced the capac ity of these supernatants to induce IgE syn-
thesis in cul tures of normal B cells. 
Induction of !gE Synthesis by Human Alloreactiue T Cell 
Clones 
It has been firmly established that T cells can activate B 
ce lls during the course of a mixed lymp hocyte reaction. How-
ever, t he low frequency of a lloreactive T cells and the concom -
ita nt activation of alloreactive suppressor/cytotoxic T ce ll s has 
limi ted the usefulness of allogeneic systems for t he act ivation 
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TABLE II. Type of interactions required for induction of lgE synthesis 
by human alloreactiue T cell clones 
Type of interaction 
Cognate stimulation 
Noncognate bystander 
lgE production by 
Atopic B cells 
++++ 
++ 
Normal B Cells 
++ 
of B cells. Recently, Lanzavecchia [25] reported that alloreac-
tive T cell clones can trigger human peripheral blood B cells to 
proliferate and sec rete high levels of immunoglobulin of all 
isotypes including IgE antibody. This report, however, did not 
identify whether atopic or nonatopic B cells were being used as 
stimulator cells in their experiments. 
We have found that B cells from both nonatopic donors as 
well as atopic donors synthesize IgE, IgG, IgM, and IgA in large 
quantities when cultured with alloreactive helper T cell clones 
that recognize determinants expressed by the stimulator B cells. 
However, only B cells from allergic donors but not from normal 
subjects can be induced to sec rete lgE via a bystander effect 
when cultured with T cell clones which are stimulated by 
antigenic determinants not expressed by the indicator B cells. 
On the other hand, IgG, JgM, and IgA synthesis could be 
enhanced to the same levels in both atopic and normal donors 
via the same bystander conditions used in the latter experi-
ments. 
These results suggest that precursor IgE B cells are present 
in normal peripheral blood although probably at lower numbers 
than found in atopic subjects. Furthermore, precursor IgE B 
cells ci rculating in nonatopic donors are in the resting or Gc 
phase and require cognate stimulation (direct T-B cell inter-
action) to induce lgE synthesis. In contrast, atopic B cells can 
be stimulated to produce lgE either under conditions of cognate 
recognition or innocent bystander where soluble factors se-
creted during the course of an alloreaction drive preactivated 
IgE B cells to produce more lgE (Table II). These experiments 
suggest that both resting and preactivated ~recur~or lgE .B cells 
are present in atopic donors. Further stud1es usmg punfied B 
cell subpopulations and better characterized soluble T cell 
factors are in progress to clarify the various stages and signals 
which allow precursor lgE B cells to differentiate into IgE 
sec reting plasma cells. 
ISOTYPE SPECIFIC REGULATION OF THE HUMAN 
IcE RESPONSE BY T CELL-DERIVED 
IcE-BINDING FACTORS 
The observations made in rodents that lgE-binding factors 
secreted by Fc, R+ T cells play an important role in the isotype 
specific regulation of lgE synthesis have stirred considerable 
interest in the culture of human peripheral blood Fc,R+ T cells 
and the isolation of lgE-binding factors from such cells. The 
subpopulation of human peripheral blood T cells that bear Fe 
receptors for IgE as detected by rosette formation with IgE-
coated ox erythrocytes is usually less than 0.1% of isolated T 
cells from nonatopic donors [29,30] . Ragweed-sensitive patients 
with allergic rhinitis , however, have been reported to have levels 
of Fc,R+ T cells as high as 0.5- 1.4% of isolated T cells [31] . 
Furthermore, Yodoi and Ishizaka [32] demonstrated thatFc,R+ 
lymphocytes could be induced in vitro by activation of lympho-
cytes from ragweed-sensitive patients with ragweed antigen E 
followed by incubation with lgE. A subsequent report by Ishi-
zaka and Sandberg [33] found that peripheral blood lympho-
cytes from ragweed-sensitive patients formed lgE binding fac-
tors when they were incubated with ragweed antigen E in the 
presence of human myeloma IgE. Culture filtrates of these cells 
inhibited rosette formation of Fc,R+ RPMI-8866 lymphoblas-
toid cells with IgE-coated ox red cells and could be absorbed 
with lgE-Sepharose. IgE binding factors were also obtained 
with human T cells activated by alloantigen or cultured in IL-
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2 containing medium with IgE. The functional activity of these 
IgE binding factors was not defined. Nevertheless, if the regu -
lation of human IgE synthesis is analogous to the rodent model, 
one would expect to find that Fc,R+ T cells from patients with 
hyper IgE states are responsible for the secretion of IgE-
potentiating factors. 
T cells from patients with the hyper IgE syndrome are 
continuously exposed to plasma IgE levels ranging from 10-
100 Jlg/ml and are frequently undergoing antigenic stimulation 
due to repeated severe infections. Based on data derived from 
experimental animals, one would expect to find increased num-
bers of circulating Fc,R+ T cells in patients with the HIE. T o 
detect Fc,R+ T cells, we incubated purified T cells from pa-
tients with hyper IgE syndrome and T cells from normal donors 
with 10 Jlg/ml human myeloma IgE followed by immunosorbent 
fluorescein-labelled goat antihuman lgE. T cells from 6 nona-
topic donors (serum IgE <50) had Fc,R+ T cells ranging from 
0- 1.0) . In contrast, the percentage of Fe R+ T cells from 2 
patients repeated on several occasions fluctuated from 2.0-
8.5%. 
Fc,R+ T cells and Fc,R- T cells were sorted on a Becton-
Dickinson FACS-IV cell sorter and long term T cell lines were 
established by maintaining them in RPMI-10% FCS, interleu-
kin-2 and irradiated autologous PBMC [34] . The majority of 
cells (75-90%) in the Fe R+ T cell lines continued to express 
Fe R after 2 months of continuous cell culture. 
Supernatants from the Fc,R+ T cell line but not the Fc,R-
T cell lines secreted factors which potentiated IgE but not IgG 
production by B cells from patients ·with allergic rhinitis but 
not B cells from normal nonatopic donors [34] (Table III) . 
These IgE-potentiating factors bound to immobilized lgE but 
not to immobilized IgG, lgA, or bovine serum albumin and lost 
their lgE-potentiating activity after incubation with insolubil-
ized trypsin or neuraminidase. Furthermore, the IgE-potentiat-
ing factor secreted by these cultures acted as a differentiation 
signal for IgE B cells rather than an isotype switch factor. A 
switch factor would be expected to induce B cells which do not 
express IgE on their surface to become IgE bearing B cells and 
to secrete lgE. However, the IgE-binding factor present in 
culture supernatants from hyper IgE patients was not found to 
be a switch factor because: (1) it did not induce normal B cells 
to secrete lgE, and (2) because removal of IgE-bearing B cells 
obtained from allergic rhinitis patients by absorption over anti-
IgE coated Petri dishes greatly reduced their lgE response to 
the lgE-binding factor but not their IgG response to PWM. 
Cytofluorographic analysis of the Fc,R+ T cell line from hyper 
lgE patients revealed a predominance of T cells bearing the 
T3, T4, Ia activated helper/inducer T cell phenotype. In this 
regard Mitsuya et a! [35] reported a patient with Sezary syn-
drome and serum IgE of 563,640 IU/ml whose peripheral T 
cells were 98-100% Leu 3a,b positive (same helper/inducer T 
cell population stained by the OKT4 monoclonal antibody). 
These T cells provided lgE specific help in vitro. 
Kishimoto and co-workers have also investigated the func -
tional activity of T cell derived lgE binding factors from pa-
TABLE III. Enhancement of lgE synthesis by supernatants ofT Cell 
lines derived from 2 patients with the hyper IgE syndrome" 
Source of Supernatant Net lgE Net lgG supernatant (pg/ml) (ng/ml) 
Medium 1,400b 1,250 
Patient #1 Fc,R+ line 11,400 1,260 
Patient #1 Fc,R-line 1,150 800 
Patient #2 Fc,R+ line 7,700 1,125 
Patient #2 Fc,R-line 1,700 1,300 
• Reproduced in part from Young MC, Leung DYM, Geha RS: 
Production of lgE potentiating fac tor in man by T cell lines bearing 
Fe receptors for lgE. Eur J Immunol, in press, [34]. 
b The effect of culture supernatants from Fe R+ and Fe R- T cell 
lines were tested on B cells from patients with allergic rhinitis. 
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t ients wi t h pulmona ry tuberculosis [36]. T ce lls from t he latte r 
patients incubated with PPD plus IgE for 5 days were found to 
h ave suppressive effect on t he polyclonal IgE response induced 
by PWM plus Staphylococcus a.ureus stra in Cowan I. The direct 
addit ion of t he e PPD-activated T cell s, as well as t he cul tured 
supernatants from t he activated T cells, suppressed t he lgE 
response without affecting the lgG response. The l gE-specitic 
suppressive ac.tivity in the supernatants was specifica lly ab-
sorbed by a n lgE co lumn but not a n lgG co lumn a nd could be 
e luted with ac id buffer. These investigato rs concluded that T 
cells from patients wi t h tubercul osis activated with PPD in t he 
presence of lgE secreted lgE binding factors which specificall y 
suppressed IgE synt hesis. 
S ince t he yield of lgE binding factors from t hese in vi t ro 
culture systems are too small for extensive characterization, 
severa l investigators have attempted to derived human T cell 
hybridomas which produce IgE-binding factors. In a recent 
report by Huff a nd Jshi zaka [37] normal huma n T cells prolif-
erating in IL-2 conta ining medium were incubated with human 
IgE, and t he cells fused with t he human T-cellline CEM. Five 
hybridomas were obtained which formed lgE-binding factors 
upon incubation wi t h human lgE. The IgE- binding factors 
formed by 4 hybridomas had a molecula r weight between 25,000 
and 30,000 whereas one byb ridoma formed lgE-binding factors 
of 30,000 to 15,000 molecular weight, molecula r sizes compa-
rable to those formed by rat lymphocytes . All the IgE binding 
factors obtained by Huff and l shi za ka had affi ni ty for concan-
avalin A, suggesting that the factor contained N-linked, man -
nose-rich oligosaccharides. Of considerable interest is that 
t hese investigators demonstrated low affinity binding of human 
IgE-binding factors for rat lgE. As a result, t hey assessed the 
effect of these purifi ed human IgE-binding factors on t he IgE 
forming cell response of rat mesenteric lymph node cells. These 
investgators found that purified lgE- binding facto r from one of 
t heir huma n T cell hybridomas se lectively potentiated t he lgE 
response. 
Recently, we successfully established human T cell hybri -
doma Jines derived from T ce lls of pat ients with hyper IgE 
syndrome [38]. Supernatants from T cell hybridomas bearing 
Fe receptors for JgE were found to secrete s ignificant amoun ts 
of soluble factors which enhanced lgE synt hesis by B cells from 
patients with allergic rhinitis. Hybridoma supernatants passed 
over l gE-conjugated Sepharose but not lgG-Sepharose lost lgE 
enha ncing activi ty, and the lgE enha ncing activity was re-
covered from the IgE-Sepha rose beads by acid elution. 
The in vivo significance of these lgE binding factors is 
suggested by the observation t hat low molecula r weight lgE 
binding facto rs can be isolated from sera of patients with HIE 
[39]. We found t hat unfractionated lgE binding factors from 2 
of 3 hyper lgE patients enhanced IgE but not lgG production 
by B cell s from patients wit h allergic rhinitis. Separation of 
t hese IgE-binding factors ove r Sepharose conjugated wi th con-
canavalin A revealed a mixt ure of lgE regulatory activities. lgE 
suppressor factors passed through the concanavalin A column 
whereas lgE enhancing factors bound to concanavalin A. In 
contrast, small molecular weight lgE binding factors from sera 
of nonatopic donors exclusively contain lgE suppressor activity. 
In 2 of 3 patients wit h t he HIE infusion with normal plasma 
resulted in decreased rates of IgE synthesis by their PBMC 
accompanied by a t ra nsito ry drop in serum lgE levels [40,41]. 
CONCLUSION 
The data presented in t his review suggest t hat T lymphocytes 
p lay an important role in the isotype-specific regu lation of the 
human lgE response (Fig 1). Resting B cells can be activated 
to secrete lgE a nd other immunoglobulin isotypes by cognate 
interaction wi th al\oreactive helper T cell clones. Subsequent 
isotype-spec ific IgE antibody secretion is modulated by IgE 
binding factors derived from Fc,R+ T ce lls. The function of 
t hese lgE binding factors a re determined by their degree of N -
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FIG 1. Summary of potential cellular interactions involved in the 
regulation of human lgE synthesis. Starting from left to right, resting 
precursor IgE B cells are activated by T-B cognate interaction. T cell -
derived IgE-binding factors (lgE B.F.) act on preactivated IgE bearing 
B cells to enhance or suppress further differentiation into lgE-secreting 
plasma cells. (*) denotes lymphocyte activation. 
glycosylation. IgE-enhancing factors are more highly glycosy-
lated than IgE suppresso r factors and require termina l sialic 
acid for t heir activity. A balance between t hese two signals will 
determine t he development of t he lgE ant ibody response. T he 
recent availability of T cell hybridomas which secrete JgE 
binding factors should make it possible to isolate these factors 
in suffic ient qua nt ity to characterize t heir physiochemical fea-
tures and study their mode of action in greater detail. It is 
hoped t hat an understanding of the mechani sms underlying 
isotype specific regulation of l gE synt hesis in man will direct 
us to more effective t herapy of lgE mediated disorders. 
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